T. P. Flynn

Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma.

L. Asmar, K. Boehm, N. D. Di Bella, 2004, Clinical lymphoma.

Phase II trial combining nab-paclitaxel (NP), gemcitabine (G), and bevacizumab (B) in patients (pts) with metastatic breast cancer (MBC): NCCTG N0735.

E. Perez, A. Dueck, D. Northfelt, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.